Ausgabe 9/2002
Inhalt (9 Artikel)
Cellular and humoral responses after multiple injections of unconjugated chimeric monoclonal antibody MOv18 in ovarian cancer patients: a pilot study
Iwona van Zanten-Przybysz, Carla Molthoff, Jacqueline Gebbinck, Silvia von Mensdorff-Pouilly, Rob Verstraeten, Peter Kenemans, René Verheijen
Induction of specific CTL by MAGE-3/CEA peptide-pulsed dendritic cells from HLA-A2/A24+ gastrointestinal cancer patients
Xishan Hao, Ying Shao, Xiubao Ren, Hong Liu, Qi Xu, Hui Li, Peng Zhang, Xiumei An, Baozhu Ren
Chronomodulated chemotherapy in metastatic gastrointestinal cancer combining 5-FU and sodium folinate with oxaliplatin, irinotecan or gemcitabine: the Jena experience in 79 patients.
Kay-Oliver Kliche, Konstantin Kubsch, Martin Raida, Rami Masri-Zada, Klaus Höffken
Brain tumor invasion model system using organotypic brain-slice culture as an alternative to in vivo model
Shin Jung, Hyun-Woo Kim, Je-Hyuk Lee, Sam-Suk Kang, Hyang-Hwa Rhu, Young-Il Jeong, Soo-Yeon Yang, Hee-Young Chung, Choon-Sang Bae, Chan Choi, Boo-Ahn Shin, Kyung-Keun Kim, Kyu-Youn Ahn
Evidence that 2-methoxyestradiol suppresses proliferation and accelerates apoptosis in normal rat growth plate chondrocytes
Jean D. Sibonga, Ulrike Sommer, Russell T. Turner
Capsaicin regulates vascular endothelial cell growth factor expression by modulation of hypoxia inducing factor-1α in human malignant melanoma cells
Prabhudas S. Patel, Shillin Yang, Aihua Li, Michelle L. Varney, Rakesh K. Singh
Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diphosphate bone scan to detect bone metastases in patients with renal cell carcinomas – a preliminary report
H. Wu, R. Yen, Y. Shen, C. Kao, C. Lin, C. Lee
Combination chemotherapy comprising 5-fluorouracil, leucovorin, etoposide, and cis-diamminedichloroplatinum for the treatment of advanced gastric cancer
Fumiro Mochizuki, Masashi Fujii, Yuichi Kasakura, Motoo Yamagata, Mitsugu Kochi, Kazuhiko Wakabayashi, Noriaki Kanamori, Tadatoshi Takayama
Recombinant human erythropoietin in combined treatment with granulocyte- or granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes
C. Kasper, J. Zahner, H. Sayer